- link Copy URL - [ Share on X ](https://twitter.com/intent/tweet?text= Gilead Ranked #4 on Fortune's 2016 "Change the World" List https://www.3blmedia.com/markdownify/node/73840?absolute=1&via=3blnews "Share on X") - [ Share on linkedin ](https://www.linkedin.com/shareArticle?mini=true&url=https://www.3blmedia.com/markdownify/node/73840?absolute=1 "Share on Linkedin") - [ Share on facebook ](https://www.facebook.com/sharer/sharer.php?u=https://www.3blmedia.com/markdownify/node/73840?absolute=1 "Share on Facebook") - [ email Share via email ](mailto:?subject= Gilead Ranked #4 on Fortune's 2016 "Change the World" List&body=News from Gilead Sciences https://www.3blmedia.com/markdownify/node/73840?absolute=1 "Share via email") [Awards & Rankings](/categories/awards-rankings) # Gilead Ranked #4 on Fortune's 2016 "Change the World" List Aug 22, 2016 11:35 AM ET Fortune has ranked Gilead 4th among 50 companies that have made an "important social or environmental impact through their profit-making strategy and operations." Criteria included measurable impact, business results and degree of innovation. Gilead's Access Operations and Emerging Markets (AOEM) program has played a critical role in expanding access to antiretroviral therapies for patients living in developing countries. Through a model of tiered pricing and by entering into voluntary licensing agreements with generic manufacturers, Gilead has been able to scale up access to medicines in the parts of the world where they are needed most. By the end of this year, 10 million people with HIV in low-and middle-income countries will be receiving a Gilead-based HIV regimen. "We are honored to be recognized by Fortune," said Gregg Alton, Executive Vice President, Commercial and Access Operations ALA, Corporate and Medical Affairs. "Gilead's AOEM program is a sustainable approach to reaching patients in developing countries, where access to medicines for diseases such as HIV is needed most. We are humbled to have been able to help millions of patients around the world through this program." For more information on Fortune's 2016 "Change the World" list, please see: [![Gilead Sciences](/sites/default/files/Clients/gilead_logo.png)](/profiles/gilead-sciences) ### More from Gilead Sciences ###### [Looking Back to the Future: Gilead’s Long-Standing Commitment To Help End the HIV Epidemic](/news/looking-back-future-gileads-long-standing-commitment-help-end-hiv-epidemic) Jul 23, 2025 9:45 AM ET ###### [Gilead Sciences - Born With HIV in the 80s: Kim’s Story of Growing Up as a Dandelion](/news/gilead-sciences-born-hiv-80s-kims-story-growing-dandelion) Jun 24, 2025 8:55 AM ET ###### [Gilead Researcher Awarded the AAAS Mani L. Bhaumik Breakthrough of the Year Award](/news/gilead-researcher-awarded-aaas-mani-l-bhaumik-breakthrough-year-award) Jun 17, 2025 8:50 AM ET ###### [Gilead Sciences: Advancing New Ways To Help End the HIV Epidemic Is the Focus of This Installment of “The Centrifuge Sessions”](/news/gilead-sciences-advancing-new-ways-help-end-hiv-epidemic-focus-installment-centrifuge-sessions) Jun 5, 2025 8:50 AM ET ###### ["The Adventure Jar” - A Children’s Book Supporting Families Impacted by Metastatic Breast Cancer (MBC) Receives Two 2025 Bronze Anvil Awards](/news/adventure-jar-childrens-book-supporting-families-impacted-metastatic-breast-cancer-mbc) Jun 3, 2025 8:40 AM ET ###### [Gilead Sciences Commemorated the Opening of the Bay Area Young Survivors Breast Cancer Memorial Garden](/news/gilead-sciences-commemorated-opening-bay-area-young-survivors-breast-cancer-memorial-garden) May 30, 2025 9:05 AM ET ###### [Transforming How Cancer Is Treated: Research Results To Be Shared at ASCO25](/news/transforming-how-cancer-treated-research-results-be-shared-asco25) May 29, 2025 8:20 AM ET ###### [Gilead Sciences and Kite Pharma To Announce Transformative Cancer Research at This Year’s American Society of Clinical Oncology (ASCO) Annual Meeting](/news/gilead-sciences-and-kite-pharma-announce-transformative-cancer-research-years-american-society) May 27, 2025 8:40 AM ET